Cite
In vivo assessment of the metabolic activity of CYP2D6 diplotypes and alleles.
MLA
Hertz, Daniel L., et al. “In Vivo Assessment of the Metabolic Activity of CYP2D6 Diplotypes and Alleles.” British Journal of Clinical Pharmacology, vol. 80, no. 5, Nov. 2015, pp. 1122–30. EBSCOhost, https://doi.org/10.1111/bcp.12665.
APA
Hertz, D. L., Snavely, A. C., McLeod, H. L., Walko, C. M., Ibrahim, J. G., Anderson, S., Weck, K. E., Magrinat, G., Olajide, O., Moore, S., Raab, R., Carrizosa, D. R., Corso, S., Schwartz, G., Peppercorn, J. M., Evans, J. P., Jones, D. R., Desta, Z., Flockhart, D. A., & Carey, L. A. (2015). In vivo assessment of the metabolic activity of CYP2D6 diplotypes and alleles. British Journal of Clinical Pharmacology, 80(5), 1122–1130. https://doi.org/10.1111/bcp.12665
Chicago
Hertz, Daniel L., Anna C. Snavely, Howard L. McLeod, Christine M. Walko, Joseph G. Ibrahim, Steven Anderson, Karen E. Weck, et al. 2015. “In Vivo Assessment of the Metabolic Activity of CYP2D6 Diplotypes and Alleles.” British Journal of Clinical Pharmacology 80 (5): 1122–30. doi:10.1111/bcp.12665.